Anacor Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Anacor Pharmaceuticals Ownership

Who owns Anacor Pharmaceuticals?

Anacor Pharmaceuticals is owned by Pfizer. It was acquired on May 16, 2016.

Anacor Pharmaceuticals Business Overview

Where is Anacor Pharmaceuticals headquartered?

Anacor Pharmaceuticals is headquartered in Palo Alto, California.

What is Anacor Pharmaceuticals’ revenue?

Anacor Pharmaceuticals disclosed revenue of 82M USD for 2015 and 21M USD for 2014.

How many employees does Anacor Pharmaceuticals have?

Anacor Pharmaceuticals has 110 employees.

What sector is Anacor Pharmaceuticals in?

Anacor Pharmaceuticals is a life science company.

When was Anacor Pharmaceuticals founded?

Anacor Pharmaceuticals was founded in 2000.

Life Science M&A Summary in 2016

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2016. The largest life science acquisition in 2016 was Baxalta - which was acquired by Shire for $32.0B.

Join Mergr to view all 295 acquisitions of life science companies in 2016, including 33 acquisitions by private equity firms, and 262 by strategics.

Anacor Pharmaceuticals, Inc.

1020 East Meadow Circle,
Palo Alto, California 94303
United States,
(650) 543-7500
www.anacor.com

Anacor Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing novel small-molecule therapeutics derived from its boron chemistry platform.


 Subscribe to unlock this and 209,235
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.